Oruka Therapeutics to Present at Multiple March Investor Conferences

Rhea-AI Summary

Oruka Therapeutics (Nasdaq: ORKA), a clinical stage biotechnology company focused on developing novel biologics for chronic skin diseases including plaque psoriasis, has announced its participation in two major investor conferences in March 2025.

The company will present at TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4th, 2025, at 10:30 AM ET, and at the Leerink Global Healthcare Conference on Wednesday, March 12th, 2025, at 8:40 AM ET.

Investors can access the webcasts and replays of these presentations through Oruka's investor events website at https://ir.orukatx.com/news-events/events-presentations.

MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced presentations at the following upcoming investor conferences:

TD Cowen’s 45^th Annual Health Care Conference
Date: Tuesday, March 4^th, 2025
Time: 10:30AM ET

Leerink Global Healthcare Conference
Date: Wednesday, March 12^th, 2025
Time: 8:40AM ET

A webcast and replay of Oruka’s presentation will be available on the Oruka investor events website at https://ir.orukatx.com/news-events/events-presentations.

About Oruka Therapeutics

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com and follow Oruka on LinkedIn.

Investor Contact: 
Alan Lada 
(650)-606-7911 
alan.lada@orukatx.com

FAQ

When is Oruka Therapeutics (ORKA) presenting at TD Cowen's Healthcare Conference in March 2025?

Oruka Therapeutics (ORKA) will present at TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4th, 2025, at 10:30 AM ET.

What time is Oruka Therapeutics (ORKA) presenting at the Leerink Global Healthcare Conference?

Oruka Therapeutics (ORKA) will present at the Leerink Global Healthcare Conference on Wednesday, March 12th, 2025, at 8:40 AM ET.

How can investors access Oruka Therapeutics' (ORKA) March 2025 conference presentations?

Investors can access the webcasts and replays of Oruka's presentations through their investor events website at https://ir.orukatx.com/news-events/events-presentations.

What therapeutic areas is Oruka Therapeutics (ORKA) focusing on in their development pipeline?

Oruka Therapeutics is developing novel biologics designed to treat chronic skin diseases, including plaque psoriasis.